1097 related articles for article (PubMed ID: 31583453)
21. Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease.
Caron M; Hoa S; Hudson M; Schwartzman K; Steele R
Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29769294
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
Qiu M; Jiang J; Nian X; Wang Y; Yu P; Song J; Zou S
Respir Res; 2021 Oct; 22(1):264. PubMed ID: 34635095
[TBL] [Abstract][Full Text] [Related]
23. Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model.
Wu W; Jordan S; Becker MO; Dobrota R; Maurer B; Fretheim H; Ye S; Siegert E; Allanore Y; Hoffmann-Vold AM; Distler O
Ann Rheum Dis; 2018 Sep; 77(9):1326-1332. PubMed ID: 29875097
[TBL] [Abstract][Full Text] [Related]
24. Are risk predicting models useful for estimating survival of patients with rheumatoid arthritis-associated interstitial lung disease?
Nurmi HM; Purokivi MK; Kärkkäinen MS; Kettunen HP; Selander TA; Kaarteenaho RL
BMC Pulm Med; 2017 Jan; 17(1):16. PubMed ID: 28086844
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis.
Kono M; Fujita Y; Takeda K; Miyashita K; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Enomoto N; Nakamura Y; Suda T; Nakamura H
Respir Med; 2019; 154():122-126. PubMed ID: 31238182
[TBL] [Abstract][Full Text] [Related]
26. The Efficacy and Safety of Pirfenidone Combined With Immunosuppressant Therapy in Connective Tissue Disease-Associated Interstitial Lung Disease: A 24-Week Prospective Controlled Cohort Study.
Wang J; Wang X; Qi X; Sun Z; Zhang T; Cui Y; Shu Q
Front Med (Lausanne); 2022; 9():871861. PubMed ID: 35646960
[TBL] [Abstract][Full Text] [Related]
27. Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature.
Ferri C; Manfredi A; Sebastiani M; Colaci M; Giuggioli D; Vacchi C; Della Casa G; Cerri S; Torricelli P; Luppi F
Autoimmun Rev; 2016 Jan; 15(1):61-70. PubMed ID: 26384526
[TBL] [Abstract][Full Text] [Related]
28. The potential utility of anterior upper lobe honeycomb-like lesion in interstitial lung disease associated with connective tissue disease.
Yamakawa H; Ogura T; Sato S; Nishizawa T; Kawabe R; Oba T; Kato A; Horikoshi M; Akasaka K; Amano M; Kuwano K; Sasaki H; Baba T; Matsushima H
Respir Med; 2020 Oct; 172():106125. PubMed ID: 32911135
[TBL] [Abstract][Full Text] [Related]
29. Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease.
Zhang Y; Li H; Wu N; Dong X; Zheng Y
Clin Rheumatol; 2017 Apr; 36(4):817-823. PubMed ID: 28191607
[TBL] [Abstract][Full Text] [Related]
30. Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survival.
Fischer A; Swigris JJ; Groshong SD; Cool CD; Sahin H; Lynch DA; Curran-Everett D; Gillis JZ; Meehan RT; Brown KK
Chest; 2008 Sep; 134(3):601-605. PubMed ID: 18403656
[TBL] [Abstract][Full Text] [Related]
31. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.
Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM
Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677
[TBL] [Abstract][Full Text] [Related]
32. Long-Term Treatment With Azathioprine and Mycophenolate Mofetil for Myositis-Related Interstitial Lung Disease.
Huapaya JA; Silhan L; Pinal-Fernandez I; Casal-Dominguez M; Johnson C; Albayda J; Paik JJ; Sanyal A; Mammen AL; Christopher-Stine L; Danoff SK
Chest; 2019 Nov; 156(5):896-906. PubMed ID: 31238042
[TBL] [Abstract][Full Text] [Related]
33. High-resolution computed tomography of the lung in patients with rheumatoid arthritis: Prevalence of interstitial lung disease involvement and determinants of abnormalities.
Salaffi F; Carotti M; Di Carlo M; Tardella M; Giovagnoni A
Medicine (Baltimore); 2019 Sep; 98(38):e17088. PubMed ID: 31567944
[TBL] [Abstract][Full Text] [Related]
34. Novel Assessment of Interstitial Lung Disease Using the "Computer-Aided Lung Informatics for Pathology Evaluation and Rating" (CALIPER) Software System in Idiopathic Inflammatory Myopathies.
Ungprasert P; Wilton KM; Ernste FC; Kalra S; Crowson CS; Rajagopalan S; Bartholmai BJ
Lung; 2017 Oct; 195(5):545-552. PubMed ID: 28688028
[TBL] [Abstract][Full Text] [Related]
35. Characteristics and risk factors of interstitial pneumonia with autoimmune features.
Vahidy S; Agyeman J; Zheng B; Donohoe K; Hambly N; Johannson KA; Assayag D; Fisher JH; Manganas H; Marcoux V; Khalil N; Kolb M; Ryerson CJ; ; Wong AW; Lok S; Morisset J; Fell CD; Shapera S; Gershon AS; Cox G; Halayko AJ; Sadatsafavi M; Wilcox PG; To T
Respir Med; 2024 Jan; 221():107500. PubMed ID: 38142756
[TBL] [Abstract][Full Text] [Related]
36. Predictors of progression in systemic sclerosis patients with interstitial lung disease.
Distler O; Assassi S; Cottin V; Cutolo M; Danoff SK; Denton CP; Distler JHW; Hoffmann-Vold AM; Johnson SR; Müller Ladner U; Smith V; Volkmann ER; Maher TM
Eur Respir J; 2020 May; 55(5):. PubMed ID: 32079645
[TBL] [Abstract][Full Text] [Related]
37. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
[TBL] [Abstract][Full Text] [Related]
38. Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis.
Tashkin DP; Volkmann ER; Tseng CH; Kim HJ; Goldin J; Clements P; Furst D; Khanna D; Kleerup E; Roth MD; Elashoff R
Ann Rheum Dis; 2016 Feb; 75(2):374-81. PubMed ID: 25452309
[TBL] [Abstract][Full Text] [Related]
39. Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
Solomon JJ; Ryu JH; Tazelaar HD; Myers JL; Tuder R; Cool CD; Curran-Everett D; Fischer A; Swigris JJ; Brown KK
Respir Med; 2013 Aug; 107(8):1247-52. PubMed ID: 23791462
[TBL] [Abstract][Full Text] [Related]
40. Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumonia.
Yoshimura K; Kono M; Enomoto Y; Nishimoto K; Oyama Y; Yasui H; Hozumi H; Karayama M; Suzuki Y; Furuhashi K; Enomoto N; Fujisawa T; Nakamura Y; Inui N; Sumikawa H; Johkoh T; Colby TV; Sugimura H; Suda T
Respir Med; 2018 Apr; 137():167-175. PubMed ID: 29605201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
